Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 471 of 5804
-
Could a quicker switch to stronger meds beat bipolar depression?
Disease control Recruiting nowBipolar disorders affect approximately 4.5 million people across the European Union (EU) and are associated with high annual healthcare and societal costs. Bipolar disorder I and II represent disorders that cause extreme fluctuation in a person's mood, energy, and ability to func…
Phase: PHASE3 • Sponsor: Dr. Inge Winter • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Gene therapy injection aims to heal diabetic foot sores
Disease control Recruiting nowThe main objective of the study is to evaluate the efficacy and safety of Neovasculgen® in a course dose of 2.4 mg in combination with standard drug therapy in patients with unilateral neuroischemic form of diabetic foot syndrome.
Phase: PHASE3 • Sponsor: JSC NextGen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Engineered immune cells take on lupus and scleroderma in new trial
Disease control Recruiting nowCAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Robots help recover brain power in Parkinson's, MS, and stroke patients
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if sensor-based robotic upper limb rehabilitation can improve cognitive and motor functions in adults with neurological and neurodegenerative disorders, including Parkinson's disease, multiple sclerosis, and stroke. The main questions i…
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New tool aims to stop depression before it starts
Prevention Recruiting nowDepression is a highly prevalent and disabling mental health problem. One way of preventing depression is to stop it before it happens through effective self-management. Working with potential users, a coach-guided, personalized depression risk communication tool (PDRC) was devel…
Phase: NA • Sponsor: Dalhousie University • Aim: Prevention
Last updated Jun 26, 2026 12:36 UTC
-
New combo drug CagriSema shows promise for major weight loss in 3-Year trial
Disease control OngoingThis study will look at how well CagriSema helps people with obesity lose weight compared to a "dummy medicine". CagriSema is a new medicine developed by Novo Nordisk. CagriSema cannot yet be prescribed by doctors. The study has two parts: First part is called the main phase and …
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for NF1 patients: experimental drug targets painful nerve tumors
Disease control Recruiting nowThe trial will be an open label, single arm, phase 2 study to assess the tolerability and efficacy of HLX-1502 in participants with NF1 that are 16 years or older in age with progressive and/or symptomatic PN. This study will also investigate the safety and efficacy of HLX-1502 i…
Phase: PHASE2 • Sponsor: Healx Limited • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a 5-Week online course turn bystanders into protectors? a trial puts the MOON program to the test
Prevention OngoingThis research project will develop, deliver, and assess the efficacy of a new sexual violence (SV) prevention program for college students. The MOON program (Moving ON against sexual violence) aims to prevent sexual violence amongst university students, who are known to be an at-…
Phase: NA • Sponsor: Universidade do Porto • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
New daily pill could stop menstrual migraines before they start
Prevention OngoingA migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often throbbing or pulsating. The headache is often accompanied by sensitivity to light, sensitivity to sound, nausea, or other symptoms. Menstrual migraine (MM) attacks are migr…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
New drug could protect unborn babies from dangerous bleeding disorder
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug aims to stop CIDP relapses in its tracks
Disease control Recruiting nowThe purpose of this Phase 3 study is to demonstrate the efficacy of claseprubart (DNTH103) as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).
Phase: PHASE3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
One shot for two threats? BioNTech tests combo Flu-COVID vaccine
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccin…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:14 UTC
-
Supercharged immune cells take on tough pancreatic cancer
Disease control Recruiting nowThis study is to investigate the safety and efficacy of gene-edited tumor infiltrating lymphocyte (GC203 TIL) therapy in patients with pancreatic ductal adenocarcinoma. Gene-edited TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lym…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for relapsed leukemia: targeted drug combo enters human trials
Disease control Recruiting nowTo determine the efficacy of the combination of tagraxofusp, cladribine, and cytarabine.
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New whooping cough vaccine passes major safety check in thousands of adults
⭐️ VACCINE ⭐️ OngoingThis pivotal safety trial aims to extend the safety database for BioNet recombinant acellular pertussis (aP) vaccine (Pertagen®) in a larger population of adults and evaluate the incidence and characteristics of adverse drug reactions (ADRs), including uncommon events, to provide…
Phase: PHASE3 • Sponsor: BioNet-Asia Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:53 UTC
-
New hope for pancreatic cancer? drug combo trial launches
Disease control Recruiting nowThis study aims to evaluate the safety and efficacy of Ivonescimab, a bispecific antibody targeting PD-1 and VEGF, in combination with stereotactic body radiotherapy (SBRT) and chemotherapy for treating locally advanced pancreatic cancer (LAPC). The Phase Ib portion is a dose-esc…
Phase: PHASE1, PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Hope for aggressive lung cancer: targeted drug trial opens
Disease control Recruiting nowThe study is being conducted to investigate the efficacy and safety of teniposide in patients with extensive-stage small cell lung cancer who have failed standard treatment and with high expression of the c-Myc-driven FBXW2/MYC gene. Based on the results, the study will explore t…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New radioactive drug targets Hard-to-Treat gut and adrenal tumors
Disease control Recruiting nowBackground: Gastrointestinal neuroendocrine tumors (GI NET) are a type of cancer that affects the stomach and intestines; pheochromocytoma/paragangliomas (PPGL) are tumors that grow in or near the adrenal glands. Both of these types of tumor have high levels of a protein called …
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill hopes to tackle Hard-to-Treat lung cancer
Disease control Recruiting nowThis study is a single arm study to access the anti-tumor efficacy and safety of sunvozertinib in untreated advanced NSCLC patients with EGFR uncommon mutations.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug trial aims to ease daily struggles of myasthenia gravis
Disease control Recruiting nowA study to evaluate the efficacy, safety and tolerability of Remibrutinib versus placebo in adult patients with Generalized Myasthenia Gravis who are on stable, standard-of-care (SOC) treatment.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC